Metastatic Non-Small Cell Lung Cancer Treatment | LUMAKRAS™ (sotorasib

- lumakrashcp.com

Learn about LUMAKRAS™ (sotorasib), a treatment option for patients with metastatic NSCLC and who have the KRAS G12C mutation. See Full Prescribing & Safety Info.

4,144,800 $ 480.00